Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) just unveiled an announcement.
Jacobio Pharmaceuticals Group Co., Ltd. has announced the composition of its board of directors and their respective roles within the company. This update includes the appointment of executive, non-executive, and independent non-executive directors, as well as their assignments to various board committees, which may influence the company’s governance and strategic direction.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and production of innovative drugs. The company operates within the healthcare industry and is listed on the stock exchange under the code 1167.
YTD Price Performance: 122.05%
Average Trading Volume: 4,603,490
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$2.23B
See more insights into 1167 stock on TipRanks’ Stock Analysis page.